Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by ...

According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 670 against its upper ...

Anthem Biosciences IPO receives tepid response, retail investors show interest, SBI Securities recommends long-term ...

Ahead of the initial share sale opening for public subscription, the unlisted shares of Anthem Biosciences were trading at ...

JM Financial Limited is acting as the book-running lead manager to the issue, and KFin Technologies Limited is the registrar.

The mainboard issue of the research-driven drug manufacturer opens for subscription on July 14. Here's everything you must ...

Smartworks Coworking’s IPO saw a decent interest from retail and non-institutional investors by Day 3, while Astec ...

Ahead of the issue launch, Anthem Biosciences has raised ₹1,016 crore from 60 institutional investors via its anchor book on ...

The company offers integrated services across the drug discovery, development, and manufacturing lifecycle for both NCEs and ...

The issue is entirely an offer for sale of 5.96 crore shares, from its promoters, investors, and other selling shareholders.